{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:56:40Z","timestamp":1790427400092,"version":"4.1.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T00:00:00Z","timestamp":1447200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100015827","name":"Lonestar Heart, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>AUGMENT-HF was an international, multicentre, prospective, open-label, randomized, controlled evaluation testing the hypothesis that Algisyl (injectable calcium alginate hydrogel) is superior to standard medical therapy (SMT) for improving functional capacity and clinical outcomes in patients with advanced heart failure (HF). We previously reported results following 6 months of follow-up. This report presents the results from 1 year of extended follow up for this clinical trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We enrolled 78 patients with advanced HF, randomized (1:1), to Algisyl with SMT or SMT alone as previously reported. Patient inclusion criteria were LVEF \u226435%, peak VO2 of 9.0\u201314.5 mL\/min\/kg and LV end-diastolic diameter (LVEDD) index 30\u201340 mm\/m2 (LVEDD\/body surface area). Patients must have been on stable, evidence-based therapy for HF. A total of 58 patients, mean age 62.3 \u00b1 9.6 years, with ischaemic (57.7%) or non-ischaemic (42.3%) HF completed 12 months of follow-up. Treatment with Algisyl was associated with improved peak VO2 at 12 months; treatment effect vs. control of +2.10 mL\/kg\/min (95% confidence interval 0.96\u20133.24, P &amp;lt; 0.001). Statistically significant improvements were observed for VO2 at anaerobic threshold, 6-min walk test distance, and NYHA functional class (all P &amp;lt; 0.001). Through 12 months of follow-up there were 4 (10.5%) deaths in the control group and 9 (22.5%) deaths in the Algisyl group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Algisyl in addition to SMT was more effective than SMT alone for providing sustained 1-year benefits in exercise capacity, symptoms, and clinical status for patients with advanced HF. These data support larger clinical evaluations of this novel therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.449","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T02:00:40Z","timestamp":1447207240000},"page":"314-325","source":"Crossref","is-referenced-by-count":157,"title":["One-Year Follow-Up Results from AUGMENT-HF: A Multicentre Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl in the Treatment of Heart Failure"],"prefix":"10.1093","volume":"18","author":[{"given":"Douglas L.","family":"Mann","sequence":"first","affiliation":[{"name":"Washington University School of Medicine, Barnes-Jewish Hospital , St. Louis, MO ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California-San Francisco , San Francisco, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.S.","family":"Coats","sequence":"additional","affiliation":[{"name":"Monash University, Melbourne, Australia and University of Warwick , Warwick ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorghe","family":"Neagoe","sequence":"additional","affiliation":[{"name":"Military Hospital Bucharest , Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinu","family":"Dragomir","sequence":"additional","affiliation":[{"name":"Spitalul Clinic De Urgenta MAI , Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Pusineri","sequence":"additional","affiliation":[{"name":"Cardio-thoracic Center, Istituto Clinico Sant\u2019Ambrogio , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Piredda","sequence":"additional","affiliation":[{"name":"Cardio-thoracic Center, Istituto Clinico Sant\u2019Ambrogio , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bettari","sequence":"additional","affiliation":[{"name":"Istituti Ospitalieri di Cremona , Cremona ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget-Anne","family":"Kirwan","sequence":"additional","affiliation":[{"name":"SOCAR Research SA , Nyon ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dowling","sequence":"additional","affiliation":[{"name":"Dowling Consulting , Louisville, KY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Volterrani","sequence":"additional","affiliation":[{"name":"IRCCS San Raffaele , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani N.","family":"Sabbah","sequence":"additional","affiliation":[{"name":"Henry Ford Health System , Detroit, MI ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Hinson","sequence":"additional","affiliation":[{"name":"LoneStar Heart Inc. , Laguna Hills, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[{"name":"Innovative Clinical Trials, Department of Cardiology and Pneumonology, University Medical Centre G\u00f6ttingen (UMG) , G\u00f6ttingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,11,11]]},"reference":[{"key":"2026011721135282100_ejhf449-bib-0001","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/heart.83.5.596","article-title":"Heart failure: epidemiology, aetiology, and prognosis of heart failure","volume":"83","author":"McMurray","year":"2000","journal-title":"Heart"},{"key":"2026011721135282100_ejhf449-bib-0002","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jtcvs.2008.08.036","article-title":"Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy","volume":"137","author":"Yu","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026011721135282100_ejhf449-bib-0003","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jchf.2013.02.006","article-title":"Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure","volume":"1","author":"Sabbah","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026011721135282100_ejhf449-bib-0004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijcard.2015.06.111","article-title":"The feasibility and safety of Algisyl-LVR\u2122 as a method of left ventricular augmentation in patients with dilated cardiomyopathy: initial first in man clinical results","volume":"199","author":"Lee","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026011721135282100_ejhf449-bib-0005","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/eurheartj\/ehv259","article-title":"A prospective comparison of alginate-hydrogel with standard medical therapy to determine impact on functional capacity and clinical outcomes in patients with advanced heart failure (AUGMENT-HF trial)","volume":"36","author":"Anker","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721135282100_ejhf449-bib-0006","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCHEARTFAILURE.111.965186","article-title":"Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training","volume":"5","author":"Swank","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026011721135282100_ejhf449-bib-0007","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2174\/1874192401004010127","article-title":"Cardiopulmonary exercise testing in patients with chronic heart failure: prognostic comparison from peak VO2 and VE\/VCO2 slope","volume":"4","author":"Sarullo","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"2026011721135282100_ejhf449-bib-0008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1378\/chest.110.2.325","article-title":"The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure","volume":"110","author":"Cahalin","year":"1996","journal-title":"Chest"},{"key":"2026011721135282100_ejhf449-bib-0009","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0002-8703(98)70219-4","article-title":"Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure?","volume":"136","author":"Roul","year":"1998","journal-title":"Am Heart J"},{"key":"2026011721135282100_ejhf449-bib-0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0002-9149(01)01975-0","article-title":"Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy","volume":"88","author":"Shah","year":"2001","journal-title":"Am J Cardiol"},{"key":"2026011721135282100_ejhf449-bib-0011","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/eurheartj\/ehi259","article-title":"The reproducibility and sensitivity of the 6-min walk test in elderly patients with chronic heart failure","volume":"26","author":"Ingle","year":"2005","journal-title":"Eur Heart J"},{"key":"2026011721135282100_ejhf449-bib-0012","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/eurheartj\/ehi162","article-title":"Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review","volume":"26","author":"Olsson","year":"2005","journal-title":"Eur Heart J"},{"key":"2026011721135282100_ejhf449-bib-0013","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1161\/01.CIR.91.9.2314","article-title":"External constraint versus active assist","volume":"91","author":"Kass","year":"1995","journal-title":"Circulation"},{"issue":"Suppl I","key":"2026011721135282100_ejhf449-bib-0014","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/ejcts\/15.Supplement_1.S12","article-title":"Partial left ventricularectomy\u2014the Batista procedure","volume":"15","author":"Batista","year":"1999","journal-title":"Eur J Cardiothor Surg"},{"key":"2026011721135282100_ejhf449-bib-0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1055\/s-2007-1013899","article-title":"Left ventricular aneurysm: a new surgical approach","volume":"37","author":"Dor","year":"1989","journal-title":"Thorac Cardiovasc Surg"},{"key":"2026011721135282100_ejhf449-bib-0016","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cardfail.2012.04.004","article-title":"Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) Trial","volume":"18","author":"Costanzo","year":"2012","journal-title":"J Card Fail"},{"key":"2026011721135282100_ejhf449-bib-0017","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.athoracsur.2007.03.095","article-title":"Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy","volume":"84","author":"Mann","year":"2007","journal-title":"Ann Thorac Surg"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.449","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/3\/314\/66382194\/eurjhf_18_3_314.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/3\/314\/66382194\/eurjhf_18_3_314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:14:10Z","timestamp":1768702450000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/18\/3\/314\/8423498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,11]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,11,11]]},"published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.449","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,3]]},"published":{"date-parts":[[2015,11,11]]}}}